Drugs / EPCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01468064 | Nov 2011 → Dec 2015 | middle cerebral artery infarction | Southern Medical University, China | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01468064 ↗ |
| Modality | Cell therapy | “Autologous ex vivo expanded EPCs were injected intravenously in the EPC group” PMID 30156755 ↗ Aug 2018 |
| Route | Intravenous | “2.5 million cells per kg autologous EPCs suspended in 100 ml saline plus 5% autologous serum are infused intravenously” NCT01468064 ↗ |